Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group ...
Learn everything you need to know about Technetium Tc99m Sestamibi-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, ...
Discover comprehensive details about Prep Kit for Technetium Tc99 Sestamibi, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it.
DRAXIMAGE, the radiopharmaceutical division of DRAXIS Health, has filed its DRAXIMAGE Sestamibi with European regulatory authorities. DRAXIMAGE Sestamibi is a generic kit for the preparation of Tc-99m ...
Sequential imaging of the heart began in 1926 with the emphasis by Blumgart and Yens [1] on detecting changes in isotopes over time. In recent years, this change in isotope has been defined as ...
Post transplant lymphoproliferative disease (PTLD) is often difficult to diagnose because of nonspecific clinical features, and unusual and/or extranodal presentations. Whole-body CT scans and gallium ...
The selection criteria identified 1,027 potentially eligible cases. Exclusion criteria were present in 309 of these leaving a final study population of 718 patients. Excluded patients were similar to ...
P-glycoprotein (Pgp) overexpression is a well-recognized factor in resistance to chemotherapy. Doxorubicin flow cytometry is used to monitor Pgp function in haematological specimens and biopsies from ...
To calculate the sensitivity, specificity and positive predictive value of 99 Tc Sestambi scan in the localization of parathyroid disease and to calculate the cost benefit of routine pre-operative ...
NOIDA, India The Food and Drug Administration has approved a generic version of the drug used in myocardial perfusion imaging to evaluate the flow of blood to the heart. Jubilant Organosys announced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results